Med Life SA · BVB:M
Med Life SA — FY2016 Earnings Presentation
11 slides from Med Life SA's earnings presentation, Feb 14, 2017
Slide 1: Conference Call Presentation for 2016 Preliminary Unaudited Consolidated Annual Financial Results
Conference Call Presentation for 2016 Preliminary Unaudited Consolidated Annual Financial Results MEDLIFE GROUP 2016 Preliminary Unaudited Consolidated Annual Financial Results
Slide 2: Legal Disclaimer
LEGAL DISCLAIMER This presentation is not, and nothing in it should be construed as, an offer, invitation or recommendation in respect of Med Life SA’s securities, or an offer, invitation or recommendation to sell, or a solicitation of an offer to buy Med Life SA’s securities. The financial informat
Slide 3: Mihail Marcu, CEO of MedLife Group
Mihail Marcu, CEO of MedLife Group : “The group delivered strong growth over 2016. On a consolidated proforma basis sales increased from RON 426.2 mln in 2015 to RON 526.8 mln in 2016 (24% up yoy), exceeding consensus expectations. Adjusted EBITDA increased from RON 61.19 mln in 2015 to RON 69.86 ml
Slide 4: Contents
CONTENTS I. BRIEF COMPANY OVERVIEW II. 2016 AT A GLANCE III. FINANCIAL HIGHLIGHTS IV. Q&A SESSION MEDLIFE GROUP 2016 Preliminary Unaudited Consolidated Annual Financial Results
Slide 5: I. MedLife Group Overview
I. MEDLIFE GROUP OVERVIEW MedLife is the largest private healthcare provider in Romania. The company operates the widest network of clinics, one of the large networks of medical laboratories, general and specialised hospitals and it has the largest client database for Healthcare Prevention Packages
Slide 6: II. 2016 at a Glance
II. 2016 AT A GLANCE ACQUISITIONS : • 100% of the shares in PRIMA MEDICAL, March 2016 • 60% of the shares in STEM CELLS BANK, March 2016 • 100% of the shares in DIAMED CENTER, March 2016 • 60% of the shares in DENT ESTET, July 2016 • 90% of the shares in CM PANDURI, October 2016 GREENFIELD OPENINGS
Slide 7: III. Financial Highlights: Consolidated Statement of Financial Position
III. FINANCIAL HIGHLIGHTS CONSOLIDATED STATEMENT OF FINANCIAL POSITION For the year ended For the period ended For the year ended VARIATION (ABS) VARIATION (%) December 31, September 30, December 31, Description 2015 2016 2016 2016 vs 2016 vs 2015 audited reviewed preliminary, unaudited 2015 Non-cur
Slide 8: III. Financial Highlights: Consolidated Pro-Forma Statement of Profit and Loss
III. FINANCIAL HIGHLIGHTS CONSOLIDATED PRO-FORMA STATEMENT OF PROFIT AND LOSS For the year ended at December 31, For the period ended at IFRS 2016 2016 Description September 30, 2016 December 31, 2015 VARIATION VARIATION preliminary, Normalization One Off preliminary, 9M Pro-forma 12M pro-forma 12M
Slide 9: Other Consolidated Financial and Operating Data
III. FINANCIAL HIGHLIGHTS OTHER CONSOLIDATED FINANCIAL AND OPERATING DATA Net Income to Adjusted EBITDA Year ended at December 31, 2016 Period ended at September, 30 2016 December, 31 2015 (RON, unless otherwise indicated) IFRS Normalisation One off Pro-forma Pro-forma Pro-forma Net income/(loss) fo
Slide 10: IV. Q&A Session
IV. Q&A SESSION MEDLIFE GROUP 2016 Preliminary Unaudited Consolidated Annual Financial Results
Slide 11: Thank You!
Thank You! © Med Life